Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-dexrazoxane | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of UQCR10 mRNA | CTD | PMID:26873546 | 1,1-dichloroethene | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of UQCR10 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UQCR10 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of UQCR10 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of UQCR10 protein | CTD | PMID:32145629 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UQCR10 mRNA | CTD | PMID:20399798 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of UQCR10 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of UQCR10 mRNA | CTD | PMID:32109520 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UQCR10 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of UQCR10 protein | CTD | PMID:31945527 | 4-hydroxyphenyl retinamide | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Fenretinide results in increased expression of UQCR10 mRNA | CTD | PMID:28973697 | 5-fluorouracil | affects expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Fluorouracil affects the expression of UQCR10 mRNA | CTD | PMID:34151400 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of UQCR10 mRNA | CTD | PMID:30047161 | aconitine | decreases expression | EXP | | 6480464 | Aconitine results in decreased expression of UQCR10 protein | CTD | PMID:33236894 | all-trans-retinoic acid | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of UQCR10 mRNA | CTD | PMID:30951980 | all-trans-retinoic acid | increases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of UQCR10 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of UQCR10 mRNA | CTD | PMID:30047161 | arsane | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UQCR10 mRNA | CTD | PMID:32045263 | arsenic atom | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UQCR10 mRNA | CTD | PMID:32045263 | arsenite(3-) | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to UQCR10 mRNA] | CTD | PMID:32406909 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of UQCR10 mRNA and bisphenol A results in increased expression of UQCR10 protein | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | bisphenol A results in increased expression of UQCR10 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | bisphenol A analog results in decreased expression of UQCR10 mRNA | CTD | PMID:32387340 | bisphenol A | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of UQCR10 mRNA | CTD | PMID:30245210 and PMID:35598803 | bisphenol A | affects expression | ISO | UQCR10 (Homo sapiens) | 6480464 | bisphenol A affects the expression of UQCR10 mRNA | CTD | PMID:30903817 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of UQCR10 mRNA | CTD | PMID:30903817 | bisphenol A | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of UQCR10 mRNA | CTD | PMID:30951980 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of UQCR10 mRNA | CTD | PMID:27571134 and PMID:34947998 | Bisphenol B | increases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of UQCR10 protein | CTD | PMID:34186270 | bisphenol F | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UQCR10 mRNA | CTD | PMID:28628672 | cadmium atom | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCR10 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCR10 mRNA | CTD | PMID:35301059 | carbamazepine | affects expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of UQCR10 mRNA | CTD | PMID:25979313 | CGP 52608 | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UCRC gene] | CTD | PMID:28238834 | clobetasol | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Clobetasol results in increased expression of UQCR10 mRNA | CTD | PMID:27462272 | clotrimazole | increases expression | EXP | | 6480464 | Clotrimazole results in increased expression of UQCR10 mRNA | CTD | PMID:30047161 | cobalt dichloride | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of UQCR10 mRNA | CTD | PMID:19376846 | copper(II) sulfate | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of UQCR10 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of UQCR10 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UQCR10 mRNA | CTD | PMID:28628672 | dorsomorphin | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UQCR10 mRNA | CTD | PMID:27188386 | doxorubicin | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of UQCR10 mRNA | CTD | PMID:26873546 | doxorubicin | increases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of UQCR10 mRNA | CTD | PMID:29803840 | doxorubicin | affects expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of UQCR10 protein | CTD | PMID:29385562 | doxorubicin | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of UQCR10 mRNA | CTD | PMID:26873546 | elemental selenium | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Selenium results in decreased expression of UQCR10 mRNA | CTD | PMID:19244175 | epoxiconazole | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of UQCR10 mRNA | CTD | PMID:35436446 | ethanol | affects expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Ethanol affects the expression of UQCR10 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UQCR10 mRNA | CTD | PMID:22206623 | glyphosate | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Glyphosate results in decreased expression of UQCR10 mRNA | CTD | PMID:37087751 | indometacin | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UQCR10 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of UQCR10 protein | CTD | PMID:32959892 | lipopolysaccharide | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of UQCR10 mRNA and [Lipopolysaccharides co-treated with Resveratrol] results in increased expression of UQCR10 mRNA | CTD | PMID:26667767 and PMID:31059760 | lipopolysaccharide | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of UQCR10 mRNA | CTD | PMID:31059760 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of UQCR10 mRNA | CTD | PMID:30047161 | methylmercury chloride | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of UQCR10 mRNA | CTD | PMID:28001369 | paracetamol | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of UQCR10 mRNA | CTD | PMID:25704631 and PMID:31059760 | paracetamol | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of UQCR10 mRNA | CTD | PMID:31059760 | PCB138 | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctanoic acid | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | perfluorooctanoic acid results in decreased expression of UQCR10 mRNA | CTD | PMID:20936131 | perfluorooctanoic acid | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | PPARA protein inhibits the reaction [perfluorooctanoic acid results in decreased expression of UQCR10 mRNA] | CTD | PMID:20936131 | resveratrol | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [Lipopolysaccharides co-treated with resveratrol] results in increased expression of UQCR10 mRNA | CTD | PMID:26667767 | SB 431542 | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UQCR10 mRNA | CTD | PMID:27188386 | selenium atom | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Selenium results in decreased expression of UQCR10 mRNA | CTD | PMID:19244175 | sodium arsenite | increases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of UQCR10 mRNA | CTD | PMID:34032870 | sodium arsenite | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of UQCR10 mRNA | CTD | PMID:36209798 | sodium arsenite | multiple interactions | ISO | Uqcr10 (Mus musculus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of UQCR10 mRNA | CTD | PMID:32045263 | sodium fluoride | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of UQCR10 protein | CTD | PMID:28918527 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of UQCR10 mRNA | CTD | PMID:30047161 | thapsigargin | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of UQCR10 mRNA | CTD | PMID:22378314 | tremolite asbestos | decreases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | tremolite results in decreased expression of UQCR10 mRNA | CTD | PMID:29279043 | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of UQCR10 protein | CTD | PMID:32519852 | triptonide | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | triptonide results in increased expression of UQCR10 mRNA | CTD | PMID:33045310 | tungsten | increases expression | ISO | Uqcr10 (Mus musculus) | 6480464 | Tungsten results in increased expression of UQCR10 mRNA | CTD | PMID:30912803 | tunicamycin | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of UQCR10 mRNA | CTD | PMID:22378314 | urethane | decreases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Urethane results in decreased expression of UQCR10 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of UQCR10 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | UQCR10 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UQCR10 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of UQCR10 mRNA | CTD | PMID:23179753 and PMID:26272509 | vincaleukoblastine | affects response to substance | ISO | UQCR10 (Homo sapiens) | 6480464 | UQCR10 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of UQCR10 mRNA | CTD | PMID:23034163 and PMID:23555832 | vorinostat | increases expression | ISO | UQCR10 (Homo sapiens) | 6480464 | vorinostat results in increased expression of UQCR10 mRNA | CTD | PMID:27188386 | |